"US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024" was originally created and ...

For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement ...

MONDAY, Nov. 4, 2024 (HealthDay News) -- Transcatheter tricuspid-valve replacement is superior to medical therapy alone for ...

A Charleston woman was always short of breath and suffered from an undertreated heart problem. A new device at MUSC has her ...

Innoventric's Trillium, now in clinical trials, is implanted in a 10-minute procedure under sedation to treat a leak in the ...

A new study published in the New England Journal of Medicine showed that improvements in symptoms and quality of life were ...

The Evoque transcatheter tricuspid valve replacement (TTVR) system continued to show significant benefits 1 year after implant, according to an update from the TRISCEND II trial. Among study ...

For patients with symptomatic and severe tricuspid regurgitation (TR), tricuspid transcatheter edge-to-edge repair ( ...

WASHINGTON, DC—An update to the TRISCEND II randomized, controlled trial of transcatheter tricuspid valve replacement (TTVR) continues to highlight the positive effects of treatment in patients with ...

Data regarding outcomes after percutaneous transcatheter tricuspid-valve replacement are needed. In this international, multicenter trial, we randomly assigned 400 patients with severe symptomatic ...